Megestrol caproate
| Megestrol caproate | |
|---|---|
| Megestrol_caproate.svg | |
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | |
| PubChem | |
| DrugBank | |
| ChemSpider | |
| KEGG | |
Megestrol caproate is a synthetic progestin used in hormone therapy. It is a derivative of megestrol, a progesterone analog, and is primarily utilized for its progestogenic effects.
Pharmacology[edit]
Mechanism of Action[edit]
Megestrol caproate functions by binding to the progesterone receptor, mimicking the effects of natural progesterone. This interaction leads to changes in the endometrium and influences the hypothalamic-pituitary-gonadal axis, ultimately affecting ovulation and menstrual cycle regulation.
Pharmacokinetics[edit]
The pharmacokinetic profile of megestrol caproate involves its absorption, distribution, metabolism, and excretion. It is administered via intramuscular injection, allowing for a slow release and prolonged action. The drug is metabolized in the liver and excreted primarily through the urinary system.
Clinical Uses[edit]
Megestrol caproate is used in various clinical settings, including:
- Hormone replacement therapy
- Contraception
- Treatment of endometriosis
- Management of menstrual disorders
Side Effects[edit]
Common side effects of megestrol caproate include:
Synthesis[edit]
The synthesis of megestrol caproate involves the chemical modification of megestrol, incorporating a caproate ester group to enhance its pharmacological properties. This modification increases the drug's lipophilicity, allowing for a longer duration of action.
Related Compounds[edit]
Megestrol caproate is related to other progestins such as medroxyprogesterone acetate and norethindrone. These compounds share similar mechanisms of action but differ in their chemical structure and clinical applications.
